west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "糖尿病视网膜病变/治疗" 52 results
  • The influence of human umbilical cord mesenchymal stem cells transplantation into vitreous cavity of diabetic rats on retinal morphology and the expression level of glial fibrillary acidic protein and rhodopsin

    ObjectiveTo observe the influence of human umbilical cord mesenchymal stem cells (hUCMSC) transplantation into vitreous cavity of diabetic rats on the retinal morphology, and the expression of glial fibrillary acidic protein (GFAP) and rhodopsin (RHO). Methods78 male Sprague-Dawley rats were used. 70 rats were injected with streptozotocin by tail vein injection at a dose of 40 mg/kg to establish the diabetes mellitus model, and another 8 rats were injected with 0.1 mol/L pH 4.0 citric acid buffer at the same dose as the normal control group. After 6 weeks of modeling, 10 rats were taken as the control group of diabetic model. hUCMSC suspension was injected into the right eye vitreous cavity of the remaining 60 rats, and the same volume of Dulbecco's modified Eagle/F12 medium was injected into the left vitreous cavity as control eyes. 1, 2 and 4 weeks after transplantation, follow-up experiments were performed. The experimental eyes were labeled as U1, U2, and U4 groups, while the control eyes were recorded as D1, D2, D4, and each group consisted of 20 eyes. After paraffin section and hematoxylin-eosin staining, the structure of the retina was observed by optical microscopy and the thickness of the outer nuclear layer and the inner nuclear layer (INL) were measured. The distribution and migration of hUCMSC in rat retina were observed by frozen section-tissue immunofluorescence assay. The mRNA and protein expression of GFAP and RHO in the retina were detected by real-time quantitative polymerase chain reaction (PCR) and Western blot assays. ResultsThe results of optical microscope observation showed the normal structure of retina in normal control group. The retinal nerve fiber layer (NFL) was thinned and the number of retinal ganglion cells (RGC) in the control group of diabetic rats was decreased. The decreased number and disorder arrangement of RGC were observed as well in U1, D1 rats. The RGC number of U2, U4, D2, D4 rats was gradually decreased. Compared with D4 group, the thickness of INL in U4 group was significantly increased (P < 0.05). Tissue immunofluorescence assay showed that hUCMSC were distributed along the inner limiting membrane in the retina of the U1 group, while the number of hUCMSC in the U2 group was gradually decreased, mainly in the NFL and ganglion cell layers. Real-time PCR and Western blot data indicated that the relative expression of GFAP mRNA and protein in the diabetic retina was significantly increased, and the relative expression of RHO mRNA and protein decreased gradually in the diabetic model group and the D1, D2, D4 groups. Compared with D2 and D4 groups, the mRNA and protein expression of GFAP in U2 and U4 groups were decreased, and the relative expression of RHO mRNA and protein were all increased (P < 0.01). ConclusionhUCMSC could migrate and integrate into the retina, after the transplantation into the vitreous cavity of diabetic rats, which reduced the expression of GFAP, but enhanced the expression of RHO.

    Release date:2016-11-25 01:11 Export PDF Favorites Scan
  • Role of stromal cell derived factor-1/CXC chemokine receptor 4 pathway in mesenchymal stem cells therapies in the management of diabetic retinopathy

    Mesenchymal stem cells (MSC) are considered to have important value in the treatment of various diseases because of their low immunogenicity, transferability, and strong tissue repair capacity. Stromal cell derived factor-1 (SDF-1) and its receptor CXC chemokine receptor 4 (CXCR4) pathway plays an important role in migration of MSC. The induction of homing of MSC to retina by regulating SDF-1/CXCR4 may exert the curative effect on diabetic retinopathy to greatest exent.

    Release date:2016-11-25 01:11 Export PDF Favorites Scan
  • Effect of recombinant adeno-associated virus mediated pigment epithelium derived factor on retina of diabetic rats

    Objective To observe the expression of the pigment epithelium derived growth factor (PEDF) in retina and the effects of PEDF for vascular endothelial growth factor (VEGF) and retinal microvascular after recombinant adeno-associated virus mediated pigment epithelium derived factor(rAAV-mediated-PEDF)transferred retina of diabetic rats. Methods Male Wister rats were induced diabetes with intraperitoneal injection of streptozocin, then divided into 1 month group (DM1), 3month group(DM3) and 6 month group randomly. In diabetic rats, right eyes were injected rAAV2CMVhPEDF into vitreum as treat group,left eyes were injected into rAAV2-CMV-GFP (1times;1011 v.g/ml) as self-control group. In normal rats, right eyes were punctured but not injected (CONf), left eyes let it be without any disposal. The levels of VEGFmRNA and hPEDFmRNA in retina were evaluated using RT-PCR in different period. The protein levels of VEGF, PEDF within the retina were determined using western blot. The change of retinal capillary were observed through retinal vascular flattening. Result The expression of hPEDFmRNA in retina was enhanced persistence after rAAV2-CMV-hPEDF injected, achieved climax until 6 months. The levels of PEDF were also incerased consecutive, the differences were statistically significant in treatment group compared with own control group (Plt;0.01). Levels of mRNA and protein of VEGF at different time-points among therapy group were not statistically significant, all obviously higher than normal (Plt;0.05),but all lower obviously than respectively own control group at the same timepoint (Plt;0.01). The morphology of retinal capillary was not different significant with normal rats in 1 month diabetic rats. Morphology changes of therapy groups were less than those of respective own control group in DM3 and DM6. Conclusion Intravitreous injection rAAV2-CMV-hPEDF can increase expression of mRNA and protein of PEDF,alleviate lesion of retinal microvascular in early period of diabetic rats and supress expression of VEGF in retina of diabetic rats.The regulation occur on mRNA level.  (Chin J Ocul Fundus Dis,2008,24:259-264)

    Release date:2016-09-02 05:46 Export PDF Favorites Scan
  • Early influence of laser photocoagulation on macular retinal thickness in diabetic retinopathy

    Objective To investigate the early influences of laser photocoagulation on macular retinal thickness in diabetic retinopathy(DR). Methods Optic coherence tomography examination was performed in 30 eyes with DR(phase Ⅲ~Ⅳ) before, and on the 3rd day and the 7th day after photocoagulation respectively. The thickness of neuroretina and pigment epithelium were measured in the areas of fovea macula and 750 μm from fovea macula. Results Three days after photocoagulation, significant thickening of neuroretina was observed in the fovea macula, which is positively related with age, fasting blood sugar and duration of DR. There was no significant changes in the thickness of pigment epithelium in macula and in the thickness of neuroretina 750 μm from fovea macula. Conclusion Significant thickening of neuroretina in fovea macula in DR early after photocoagulation reveals progressed macular edema induced by photocoagulation which is positively related with age, fasting blood sugar and duration of DR. (Chin J Ocul Fundus Dis, 2002, 18: 31-33)

    Release date:2016-09-02 06:01 Export PDF Favorites Scan
  • Therapeutic effect of laser photocoagulation on diabetic retinopathy at different stages

    bjective To observe the therapeutic effect of laser photocoagulation on diabetic retinopathy (DR)at different stages.Methods A total of 534 eyes of 304 patients with DR diagnosed by fundus fluorescein angiography (FFA) were enrolled in this study. In the 534 eyes, 92 with nonproliferative DR (NPDR) had the bestcorrected visual acuity(BCVA) of 0.52plusmn;0.32,108 with preproliferative DR (PPDR) had the BCVA of 0.49plusmn;0.23,196 with early PDR had the BCVA of 0.20plusmn;0.31,and 138 with highrisk PDR had the BCVA of 0.17plusmn;0.22. According to the rules of ETDRS, retinal photocoagu1ation,pan retinal photocoagu1ation or extrapanretinal photocoagu1ation were performed on the paitents with NPDR,PPDR,and highrisk PDR,respectivelyThe patients were followed up for 10-18 months after the operations and the results of the examinations at the last time were regarded as the criteria for judgement. The examination of BCVA and ocular fundus and FFA were performed with the time interval of 3 months.The judgement for BCVA was(1)improved:improved ge;2 lines;(2) kept still: changed within 2 lines;(3)decreased:decreased ge;2 lines.And the effect on BCVA was positve when it was improved or kept still.The judgement for the therapeutic effect on DR was:retinal edeama was alleviated,leakage of hemorrhage was obsorbed,microaneurysm disappeared or decreased, neovascularization (NV) was relieved completely or partly,nonperfusion area disappeared or narrowed, and no new NV or nonperfusion area came into being. Results After the operations, BCVA in NPDR,PPDR and early PDR groups was improved or kept still in 73(79.3%),83(76.9%),and 146 eyes (74.5%), respectively,without any statistical difference among these three groups(P>0.05).BCVA in highrisk PDR group was significant lower than that in the NPDR,PPDR,and early PDR groups (P<0.05). The positive rate of therapeutic effect on DR was 89.1%,85.2%,82.7% in NPDR,PPDR,and early PDR groups, respectively without any statistical difference among the groups(P>0.05). The positive rate of therapeutic effect on DR in highrisk PDR group was significant lower than that in the NPDR,PPDR,and early PDR groups(P<0.05). Conclusion The prognosis of DR at different stages after laser photocoagulation is different;timely and effective laser photocoagulation is important to prevent the development of the disease and decrease the blindness rate.

    Release date:2016-09-02 05:42 Export PDF Favorites Scan
  • 糖尿病黄斑水肿的治疗现状

    激光光凝、玻璃体切割手术及药物治疗是目前治疗糖尿病黄斑水肿(DME)的主要方法。传统激光光凝治疗相对安全、疗效作用持久,仍具有其无法取代的优势;玻璃体切割手术能解除一部分患者的DME,但手术风险及创伤较大;糖皮质激素类药物由于其明确的副作用,不能作为主要治疗方法;抗血管内皮生长因子药物治疗能从发病机制上阻断DME的发生发展,其疗效已经得到循证医学的认可,具有良好的应用前景,但疗效相对较短,反复治疗的潜在危险及全身副作用需要更大样本量的长期前瞻性研究进一步验证;联合治疗减少重复治疗次数、提高疗效、增强安全性,可成为将来的发展趋势。

    Release date:2016-09-02 05:18 Export PDF Favorites Scan
  • 糖尿病性黄斑水肿的药物治疗进展

    糖尿病性黄斑水肿(DME)是导致糖尿病视网膜病变(DR)患者视力下降的主要原因之一。目前,激光光凝和玻璃体手术治疗已经明显降低了DR的致盲率,但二者对于改善视力的疗效、特别是对于糖尿病性黄斑水肿的疗效尚不能令人满意。随着对DR发病机制的深入研究,目前已开发出多种药物用于防治DR,特别是在治疗DME方面取得了一定的疗效,包括糖皮质激素、抗血管内皮生长因子药物、非甾体类药物、降血脂药物、血管紧张素抑制剂和选择性蛋白激酶Cbeta;抑制剂。本文就近几年来药物治疗糖尿病性黄斑水肿的进展作一综述。

    Release date:2016-09-02 05:40 Export PDF Favorites Scan
  • Macular choroidal thickness in patients with diabetic retinopathy before and after laser treatment

    ObjectiveTo observe the changes of macular choroidal thickness before and after laser treatment for diabetic retinopathy patients. Methods For patients with diabetes by fundus fluorescein angiography (FFA) examination, diagnosed as severe non-proliferative and proliferative diabetic retinopathy and in accordance with the laser photocoagulation treatment indications of 23 patients (45 eyes) included in the study. There were 10 cases of male, 13 cases of female; the average age was (55.48±5.43) years old. All patients underwent macular grid laser photocoagulation and pan-retinal photocoagulation. The macular choroidal thickness before and after laser treatment was measured by enhanced depth imaging technique of optical coherence tomography during follow-up at 1, 2, 3 weeks and one month at specific sites of choroidal. The specific sites included subfoveal choroidal thickness (SFCT), from the foveal 1mm, 3mm, 6mm distance of nasal choroidal thickness (NCT) and temporal choroidal thickness (TCT). ResultsOne week after the treatment, SFCT, NCT1 mm, NCT3 mm, TCT1 mm, TCT3 mm, TCT6 mm were obviously thickening(t=4.728, 4.422, 3.759, 3.743, 5.713, 2.502; P < 0.05). Two weeks after the treatment the SFCT, NCT1 mm, NCT3 mm, TCT1 mm, TCT3 mm were decreased gradually(t=3.189, 2.122, 2.742, 2.196, 2.076; P < 0.05).The choroidal thickness returned to pretreatment level from 2 weeks to 4 weeks after treatment, the NCT6 mm had no obvious change in the whole treatment period(P > 0.05). ConclusionThe choroidal thickness was significantly thicker after laser photocoagulation treatment within 1 week, with the time prolonging the choroidal thickness gradually decreases.

    Release date: Export PDF Favorites Scan
  • 糖尿病视网膜病变全视网膜光凝前后的视网膜中央动静脉多普勒超声血流变化

    Release date:2016-09-02 05:48 Export PDF Favorites Scan
  • 抗血管内皮生长因子单克隆抗体bevacizumab玻璃体腔单次注射后对侧眼缺血性视网膜病变一例

    Release date:2016-09-02 05:26 Export PDF Favorites Scan
6 pages Previous 1 2 3 ... 6 Next

Format

Content